The Sweet Rise of the Korean Melon: Debunking the Myth Behind Its Seeds
As the 'chamoe' captures the tastes of Japanese consumers, health authorities clarify common misconceptions regarding its nutritional value and...
Search results for "MFDS"
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair
With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active ingredient: sotatercept) remaining in...
Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical...
Fast-Tracking Biosimilars: South Korea to Waive Phase 3 Clinical Trials Under New Guidelines
South Korean regulators have revised requirements to significantly reduce the time and financial burden of biosimilar...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Global Appetite for K-Food Drives Record Export Surge as Instant Noodles and Frozen Gimbap Soar
The global spread of Korean pop culture continues to drive unprecedented overseas demand for K-food products, with...
Precision Beyond the Knee: Why Robotic Hip Surgery is the Next Medical Frontier
A powerful robotic wave is sweeping through the joint replacement market. For knee replacements, robot-assisted...
Supplementing for Success: How to Match Your Nutrient Intake to Your Age
It is a common refrain: “I received these supplements as a gift, but I’m not sure if they’re actually right for me.
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?
A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...